Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Processa Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −2 vs. Q3 2023
- Shares held
- 1.13M
- −255.3K (−18.4%) vs. Q3 2023
- Total value
- $376.5K
- +$26.7K (+7.6%) vs. Q3 2023
- New holders
- 4
- 6 more added
- Sold out
- 6
- 5 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $498.3K |
| Q1 2026 | 10 | $448.5K |
| Q4 2025 | 10 | $331.0K |
| Q3 2025 | 14 | $341.9K |
| Q2 2025 | 13 | $75.9K |
| Q1 2025 | 9 | $63.2K |
| Q4 2024 | 8 | $87.5K |
| Q3 2024 | 8 | $66.5K |
| Q2 2024 | 9 | $101.0K |
| Q1 2024 | 11 | $251.5K |
| Q4 2023 | 18 | $376.5K |
| Q3 2023 | 20 | $349.8K |
| Q2 2023 | 19 | $691.4K |
| Q1 2023 | 22 | $852.6K |
| Q4 2022 | 18 | $1.28M |
| Q3 2022 | 18 | $2.58M |
| Q2 2022 | 18 | $3.24M |
| Q1 2022 | 18 | $3.22M |
| Q4 2021 | 19 | $6.47M |
| Q3 2021 | 18 | $12.2M |
| Q2 2021 | 18 | $11.2M |
| Q1 2021 | 17 | $12.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Processa Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 293 | $98 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,195 | $400 | 0.00% | −8,899−88.2% | Reduced |
| Allworth Financial LP | 1,700 | $569 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,247 | $1.09K | 0.00% | +9+0.3% | Added |
| HRT Financial LP | 11,717 | $3.00K | 0.00% | −7,629−39.4% | Reduced |
| Courier Capital LLC | 12,000 | $4.01K | 0.00% | +12,000 | New |
| McCollum Christoferson Group LLC | 12,500 | $4.18K | 0.00% | +12,500 | New |
| Two Sigma Investments, LP | 18,677 | $6.25K | 0.00% | +18,677 | New |
| Northern Trust Corp | 28,139 | $9.41K | 0.00% | +12,738+82.7% | Added |
| State Street Corp | 42,786 | $14.3K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 46,306 | $15.0K | 0.00% | −76−0.2% | Reduced |
| Renaissance Technologies LLC | 58,200 | $19.0K | 0.00% | +4,300+8.0% | Added |
| Coastal Bridge Advisors, LLC | 64,956 | $21.7K | 0.01% | +12,456+23.7% | Added |
| Spinnaker Trust | 76,865 | $25.7K | 0.00% | +76,865 | New |
| UBS Group AG | 80,023 | $26.8K | 0.00% | +79,316+11,218.7% | Added |
| Geode Capital Management, LLC | 122,033 | $40.8K | 0.00% | −30,637−20.1% | Reduced |
| Vanguard Group Inc | 234,653 | $78.5K | 0.00% | −109,772−31.9% | Reduced |
| Citadel Advisors LLC | 315,410 | $105.5K | 0.00% | +149,186+89.7% | Added |
| Walleye Capital LLC | 0 | $0 | 0.00% | −419,277−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −25,930−100.0% | Sold out |
| Mirador Capital Partners LP | 0 | $0 | 0.00% | −19,516−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,617−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |